Cargando…

Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients

AIMS/INTRODUCTION: To evaluate serum 25‐hydroxyvitamin D(3) (25(OH)D(3)) in newly diagnosed type 2 diabetes patients and to explore the associations of 25(OH)D(3) with insulin resistance and β‐cell function. MATERIALS AND METHODS: A total of 97 newly diagnosed type 2 diabetes patients and 69 healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Zhang, Xuejun, Bao, Mingjing, Liu, Limei, Xian, Yang, Wu, Jichuan, Li, Pengqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773668/
https://www.ncbi.nlm.nih.gov/pubmed/27042275
http://dx.doi.org/10.1111/jdi.12381
_version_ 1782418783475859456
author Yang, Yan
Zhang, Xuejun
Bao, Mingjing
Liu, Limei
Xian, Yang
Wu, Jichuan
Li, Pengqiu
author_facet Yang, Yan
Zhang, Xuejun
Bao, Mingjing
Liu, Limei
Xian, Yang
Wu, Jichuan
Li, Pengqiu
author_sort Yang, Yan
collection PubMed
description AIMS/INTRODUCTION: To evaluate serum 25‐hydroxyvitamin D(3) (25(OH)D(3)) in newly diagnosed type 2 diabetes patients and to explore the associations of 25(OH)D(3) with insulin resistance and β‐cell function. MATERIALS AND METHODS: A total of 97 newly diagnosed type 2 diabetes patients and 69 healthy controls were recruited. Serum 25(OH)D(3) was determined using high‐pressure liquid chromatography. Insulin resistance was measured using a homeostasis model assessment of insulin resistance (HOMA‐IR). β‐Cell function was determined using the HOMA β‐cell function index (HOMA‐β), early‐phase insulin secretion index (ΔI30/ΔG30) and area under the insulin curve (AUCins). Correlation analysis was carried out using Pearson's correlation and multiple stepwise regression analysis. RESULTS: Serum 25(OH)D(3) was much lower in patients with newly diagnosed type 2 diabetes (t = −13.00, P < 0.01), and the prevalence of hypovitaminosis 25(OH)D(3) was 62.9% (61/97) in diabetic patients. Among the diabetic patients, patients with hypovitaminosis 25(OH)D(3) showed higher glycosylated hemoglobin and AUCglu (P < 0.01) as well as lower HOMA‐β, ΔI30/ΔG30 and AUCins. Serum 25(OH)D(3) was independently positively correlated with ΔI30/ΔG30 and AUCins (P < 0.05), but was not significantly correlated with either HOMA‐IR or HOMA‐β. Only triglycerides, glycosylated hemoglobin and ΔI30/ΔG30 emerged as independent factors associated with serum 25(OH)D(3) in both diabetes patients and the health control group. CONCLUSIONS: The present results further showed a low serum 25(OH)D(3) concentration in patients with newly diagnosed type 2 diabetes. 25(OH)D(3) deficiency is associated with disturbances in glucose metabolism and lipid metabolism. Serum 25(OH)D(3) is not correlated with basal insulin resistance or β‐cell function, but is significantly positively correlated with glucose‐stimulated insulin secretion and β‐cell function.
format Online
Article
Text
id pubmed-4773668
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47736682016-04-01 Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients Yang, Yan Zhang, Xuejun Bao, Mingjing Liu, Limei Xian, Yang Wu, Jichuan Li, Pengqiu J Diabetes Investig Articles AIMS/INTRODUCTION: To evaluate serum 25‐hydroxyvitamin D(3) (25(OH)D(3)) in newly diagnosed type 2 diabetes patients and to explore the associations of 25(OH)D(3) with insulin resistance and β‐cell function. MATERIALS AND METHODS: A total of 97 newly diagnosed type 2 diabetes patients and 69 healthy controls were recruited. Serum 25(OH)D(3) was determined using high‐pressure liquid chromatography. Insulin resistance was measured using a homeostasis model assessment of insulin resistance (HOMA‐IR). β‐Cell function was determined using the HOMA β‐cell function index (HOMA‐β), early‐phase insulin secretion index (ΔI30/ΔG30) and area under the insulin curve (AUCins). Correlation analysis was carried out using Pearson's correlation and multiple stepwise regression analysis. RESULTS: Serum 25(OH)D(3) was much lower in patients with newly diagnosed type 2 diabetes (t = −13.00, P < 0.01), and the prevalence of hypovitaminosis 25(OH)D(3) was 62.9% (61/97) in diabetic patients. Among the diabetic patients, patients with hypovitaminosis 25(OH)D(3) showed higher glycosylated hemoglobin and AUCglu (P < 0.01) as well as lower HOMA‐β, ΔI30/ΔG30 and AUCins. Serum 25(OH)D(3) was independently positively correlated with ΔI30/ΔG30 and AUCins (P < 0.05), but was not significantly correlated with either HOMA‐IR or HOMA‐β. Only triglycerides, glycosylated hemoglobin and ΔI30/ΔG30 emerged as independent factors associated with serum 25(OH)D(3) in both diabetes patients and the health control group. CONCLUSIONS: The present results further showed a low serum 25(OH)D(3) concentration in patients with newly diagnosed type 2 diabetes. 25(OH)D(3) deficiency is associated with disturbances in glucose metabolism and lipid metabolism. Serum 25(OH)D(3) is not correlated with basal insulin resistance or β‐cell function, but is significantly positively correlated with glucose‐stimulated insulin secretion and β‐cell function. John Wiley and Sons Inc. 2015-07-08 2016-03 /pmc/articles/PMC4773668/ /pubmed/27042275 http://dx.doi.org/10.1111/jdi.12381 Text en © 2015 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Yang, Yan
Zhang, Xuejun
Bao, Mingjing
Liu, Limei
Xian, Yang
Wu, Jichuan
Li, Pengqiu
Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients
title Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients
title_full Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients
title_fullStr Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients
title_full_unstemmed Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients
title_short Effect of serum 25‐hydroxyvitamin D(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients
title_sort effect of serum 25‐hydroxyvitamin d(3) on insulin resistance and β‐cell function in newly diagnosed type 2 diabetes patients
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773668/
https://www.ncbi.nlm.nih.gov/pubmed/27042275
http://dx.doi.org/10.1111/jdi.12381
work_keys_str_mv AT yangyan effectofserum25hydroxyvitamind3oninsulinresistanceandbcellfunctioninnewlydiagnosedtype2diabetespatients
AT zhangxuejun effectofserum25hydroxyvitamind3oninsulinresistanceandbcellfunctioninnewlydiagnosedtype2diabetespatients
AT baomingjing effectofserum25hydroxyvitamind3oninsulinresistanceandbcellfunctioninnewlydiagnosedtype2diabetespatients
AT liulimei effectofserum25hydroxyvitamind3oninsulinresistanceandbcellfunctioninnewlydiagnosedtype2diabetespatients
AT xianyang effectofserum25hydroxyvitamind3oninsulinresistanceandbcellfunctioninnewlydiagnosedtype2diabetespatients
AT wujichuan effectofserum25hydroxyvitamind3oninsulinresistanceandbcellfunctioninnewlydiagnosedtype2diabetespatients
AT lipengqiu effectofserum25hydroxyvitamind3oninsulinresistanceandbcellfunctioninnewlydiagnosedtype2diabetespatients